Canada-based home healthcare services provider 360Medlink has signed a definitive merger agreement with generative AI (GenAI) healthcare firm VIIGROUP.
The merger will combine VIIGROUP’s AI customer engagement platform with 360Medlink’s expertise in digital care management across different populations and conditions.
It aims to enhance the personalised patient experience and clinical research, advancing patient engagement and driving better outcomes.
The transaction is expected to be completed soon, subject to customary closing conditions.
360Medlink offers digital therapeutics (DTx) personalised patient experience and clinical research to advance patient engagement and drive better outcomes.
It has expertise in digital therapeutics, virtual health, and clinical research, offering advanced solutions for treatment management and clinical trial management.
VIIGROUP provides AI-powered life sciences and healthcare transformation solution to improve atient and physician engagement and outcomes.
Its offerings include the VII LiveAgent AI, a real-time AI visual conversational assistant designed for personalised healthcare delivery.
Clinikly.ai Treatment Companion is an advanced AI-powered solution that supports patients throughout their treatment journey.
Persist-Rx is a Class-I Medical Device designed to deliver treatment monitoring and management and provide AI support and data insights to healthcare providers.
Both companies have established as strong partners to physicians, pharmaceutical and biotechnology companies, health systems, and contract research organisations.
Their combined, AI-powered therapeutic solutions would help life sciences organisations improve patient care experience, engagement, and retention through user-friendly solutions.
They will simplify efficiency for clinicians by reducing administrative burdens, increasing satisfaction, and optimising care delivery.
Furthermore, the advanced AI-powered solutions deliver customised healthcare insights to drive data-driven decisions and improve clinical outcomes.
